Gestational diabetes & diabetes in pregnancy

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content

Cardiovasc DiabetolPublished Mechanistic study

Authors' conclusion

PNPLA3 rs738409 risk genotype completely decoupled the direct correlation between two surrogate markers of insulin resistance: TyG and HOMA2-IR confirming our hypothesis. The liver lipid content increased in parallel with the HOMA2-IR independent of genotype, in contrast to the TyG index where the risk genotype abolished the correlation. This phenomenon seems to be related to the nature of hepatic fat accumulation and to the different concepts establishing the two insulin resistance markers.

Study context

Population
Women from a prior GDM-genetic study recalled by PNPLA3 rs738,409 CC and GG genotypes; metabolic phenotyping with 75 g OGTT and hepatic triglyceride content (HTGC) by MR
Participants
39 women
Comparison
PNPLA3 rs738409 GG vs CC genotype
Outcome
Correlations among TyG index, HOMA2-IR and hepatic triglyceride content (HTGC), stratified by PNPLA3 rs738409 genotype
Methodological detailsgenotype-stratified recall study
  • Genotype-stratified recall study

Main finding

As reported in the abstract

Correlations of HOMA2-IR, TyG and HTGC
HOMA2-IR vs TyG correlation, CC
R = 0.52, p = 0.0054
HOMA2-IR vs TyG correlation, GG
completely abolished
HOMA2-IR vs HTGC, entire population
R = 0.69, p < 0.0001
HOMA2-IR vs HTGC, CC
R = 0.62, p = 0.0006
HOMA2-IR vs HTGC, GG
R = 0.74, p = 0.0058
TyG vs HTGC, CC
R = 0.42, p = 0.0284
TyG vs HTGC, GG
not significant

Further findings

TG vs HTGC correlation (TyG components assessed separately)

TG vs HTGC, CC
R = 0.41, p = 0.0335
Similar pattern to TyG vs HTGC

Original publication

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content. Cardiovasc Diabetol. Published 21 March 2023. doi:10.1186/s12933-023-01792-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.